Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items (2017 - 2022)

Historic Non-cash Items for Arcus Biosciences (RCUS) over the last 6 years, with Q4 2022 value amounting to $50.0 million.

  • Arcus Biosciences' Non-cash Items rose 86932.17% to $50.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $50.0 million, marking a year-over-year increase of 86932.17%. This contributed to the annual value of $50.0 million for FY2022, which is 86932.17% up from last year.
  • Per Arcus Biosciences' latest filing, its Non-cash Items stood at $50.0 million for Q4 2022, which was up 86932.17% from $5.2 million recorded in Q4 2021.
  • Arcus Biosciences' 5-year Non-cash Items high stood at $50.0 million for Q4 2022, and its period low was $1.1 million during Q4 2019.
  • Its 5-year average for Non-cash Items is $14.0 million, with a median of $5.2 million in 2021.
  • Per our database at Business Quant, Arcus Biosciences' Non-cash Items plummeted by 8958.82% in 2019 and then surged by 86932.17% in 2022.
  • Quarter analysis of 5 years shows Arcus Biosciences' Non-cash Items stood at $11.0 million in 2018, then tumbled by 89.59% to $1.1 million in 2019, then surged by 143.87% to $2.8 million in 2020, then skyrocketed by 84.68% to $5.2 million in 2021, then soared by 869.32% to $50.0 million in 2022.
  • Its Non-cash Items stands at $50.0 million for Q4 2022, versus $5.2 million for Q4 2021 and $2.8 million for Q4 2020.